Literature DB >> 9371653

Reduced viral load and lack of CD4 depletion in SCID-hu mice infected with Rev-independent clones of human immunodeficiency virus type 1.

A Valentin1, G Aldrovandi, A S Zolotukhin, S W Cole, J A Zack, G N Pavlakis, B K Felber.   

Abstract

The posttranscriptional control element CTE of the simian type D retrovirus has been shown to support replication of Rev-Rev-responsive-element (RRE)-deficient molecular clones of human immunodeficiency virus type 1 (HIV-1). Upon infection of peripheral blood mononuclear cells in vitro, these CTE-containing Rev-independent viruses that are nef+ or nef-minus showed lower replicative capacity and infectivity than the wild-type HIV-1. We studied the effects of Rev-RRE replacement by the CTE on HIV-1 expression with SCID-hu mice. The nef+ and nef-minus Rev-independent viruses established infection with kinetics slower than that of the nef-minus NL4-3. Most importantly, no depletion of CD4-bearing thymocytes was observed after 6 weeks for mice infected with these Rev-independent viruses. This is in contrast to the infection with both wild-type and nef-minus viruses, which led to varying depletion of thymocytes. These data suggest an attenuated phenotype for growth and cytotoxicity of the Rev-independent HIV-1 clones in SCID-hu mice, independent of the presence of Nef. The mutant viruses, which have the essential Rev-RRE regulatory system eliminated, display a distinct phenotype not previously observed with HIV mutant viruses having deletions of accessory genes. Therefore, replacement of the Rev-RRE regulatory axis may generate viruses with altered biological properties in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371653      PMCID: PMC230297     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function.

Authors:  C Tabernero; A S Zolotukhin; A Valentin; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

2.  Replacement of posttranscriptional regulation in SIVmac239 generated a Rev-independent infectious virus able to propagate in rhesus peripheral blood mononuclear cells.

Authors:  A von Gegerfelt; B K Felber
Journal:  Virology       Date:  1997-06-09       Impact factor: 3.616

3.  Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ.

Authors:  G Wolff; S Worgall; N van Rooijen; W R Song; B G Harvey; R G Crystal
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

4.  Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

Authors:  J S McDougal; S P Cort; M S Kennedy; C D Cabridilla; P M Feorino; D P Francis; D Hicks; V S Kalyanaraman; L S Martin
Journal:  J Immunol Methods       Date:  1985-01-21       Impact factor: 2.303

Review 5.  Pathogenic diversity of simian immunodeficiency viruses.

Authors:  V M Hirsch; P R Johnson
Journal:  Virus Res       Date:  1994-05       Impact factor: 3.303

6.  Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.

Authors:  A S Zolotukhin; A Valentin; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity.

Authors:  B D Jamieson; G M Aldrovandi; V Planelles; J B Jowett; L Gao; L M Bloch; I S Chen; J A Zack
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

8.  Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.

Authors:  G M Aldrovandi; J A Zack
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates.

Authors:  B D Jamieson; S Pang; G M Aldrovandi; J Zha; J A Zack
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Lack of dichotomy between virus load of peripheral blood and lymph nodes during long-term simian immunodeficiency virus infection of African green monkeys.

Authors:  B Beer; J Scherer; J zur Megede; S Norley; M Baier; R Kurth
Journal:  Virology       Date:  1996-05-15       Impact factor: 3.616

View more
  7 in total

1.  Rev-independent simian immunodeficiency virus strains are nonpathogenic in neonatal macaques.

Authors:  Agneta S von Gegerfelt; Vladimir Liska; Pei-Lin Li; Harold M McClure; Kyoji Horie; Filomena Nappi; David C Montefiori; George N Pavlakis; Marta L Marthas; Ruth M Ruprecht; Barbara K Felber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Persistent infection of rhesus macaques by the rev-independent Nef(-) simian immunodeficiency virus SIVmac239: replication kinetics and genomic stability.

Authors:  A S von Gegerfelt; V Liska; N B Ray; H M McClure; R M Ruprecht; B K Felber
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Bovine leukemia virus structural gene vectors are immunogenic and lack pathogenicity in a rabbit model.

Authors:  L Kucerova; V Altanerova; C Altaner; K Boris-Lawrie
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 4.  Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  J Virol       Date:  2007-03-28       Impact factor: 5.103

5.  Identification of a novel posttranscriptional regulatory element by using a rev- and RRE-mutated human immunodeficiency virus type 1 DNA proviral clone as a molecular trap.

Authors:  F Nappi; R Schneider; A Zolotukhin; S Smulevitch; D Michalowski; J Bear; B K Felber; G N Pavlakis
Journal:  J Virol       Date:  2001-05       Impact factor: 6.549

6.  RTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAs.

Authors:  Sergey Smulevitch; Jenifer Bear; Candido Alicea; Margherita Rosati; Rashmi Jalah; Andrei S Zolotukhin; Agneta von Gegerfelt; Daniel Michalowski; Christoph Moroni; George N Pavlakis; Barbara K Felber
Journal:  Retrovirology       Date:  2006-01-13       Impact factor: 4.602

7.  Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals.

Authors:  Cheryl A Stoddart; Cheryl A Bales; Jennifer C Bare; George Chkhenkeli; Sofiya A Galkina; April N Kinkade; Mary E Moreno; José M Rivera; Rollie E Ronquillo; Barbara Sloan; Paul L Black
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.